Skip to main
TDOC
TDOC logo

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 25%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health Inc. experienced significant growth in its Integrated Care membership, increasing to 102.5 million from 91.8 million a year ago, indicating strong demand for its virtual care services. The company generated approximately $15.9 million in operating cash flow, with $1,193.3 million in cash and cash equivalents, highlighting its solid financial position. Management also anticipates continued membership growth and stable Customer Acquisition Costs (CAC), which contributes positively to the outlook for revenue and overall business expansion.

Bears say

Teladoc Health has encountered a significant decline in its BetterHelp segment, with users dropping to 397,000, reflecting a decrease from both the previous quarter and the same quarter last year, signaling potential issues in customer retention and engagement. Furthermore, the company's fiscal year 2025 topline guidance remains unchanged; however, the expected inclusion of Uplift is anticipated to negatively impact BetterHelp and consolidated margins, resulting in a revised EBITDA outlook. Additionally, the first quarter of fiscal year 2025 presented a GAAP EPS loss of ($0.53) due to goodwill impairment, juxtaposed with a total revenue decline of 2.6% year-over-year, primarily driven by a 10.8% contraction in the BetterHelp segment.

Teladoc (TDOC) has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 25% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 16 analysts, Teladoc (TDOC) has a Hold consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.97, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.97, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.